Form 4: Evolus, Inc. Officer Rui Avelar Sells Shares to Cover Tax Obligations

Rui Avelar, Chief Medical Officer & Head of Research and Development at Evolus, Inc., sold 3,385 shares of common stock on May 12, 2025, to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On May 12, 2025, Rui Avelar, Chief Medical Officer & Head of Research and Development at Evolus, Inc., sold 3,385 shares of common stock.
• The shares were sold at a price of $9.8661 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of certain restricted stock units.
• Following the transaction, Avelar directly owns 359,082 shares of Evolus, Inc. common stock.
• The sale was conducted under a Rule 10b5-1 trading plan.

Sentiment

Score: 5

Explanation: The document is a standard SEC Form 4 filing, indicating a routine transaction. The sale is related to tax obligations, which is a neutral event.

Industry Context

Sales of shares by company insiders are a common occurrence, often related to compensation or diversification strategies. The use of a 10b5-1 trading plan suggests the insider planned the sale in advance.

Stakeholder Impact

• The sale of shares by an officer could have a minor impact on shareholder sentiment, but the pre-planned nature of the sale under Rule 10b5-1 mitigates potential concerns.

Key Dates

Keywords

Evolus, Inc., Rui Avelar, Form 4, Stock Sale, Officer Transaction, Rule 10b5-1, Tax Obligations, Restricted Stock Units